BSE Live
Dec 29, 16:01Prev. Close
416.55
Open Price
418.10
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 29, 15:49Prev. Close
417.30
Open Price
417.30
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
414.00 (371)
| Cash Flow of Aarti Drugs (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 174.97 | 127.62 | 112.21 | 107.78 | 92.84 | |
| Net CashFlow From Operating Activities | 196.15 | 147.30 | 61.93 | 174.41 | 125.27 | |
| Net Cash Used In Investing Activities | -29.35 | -59.33 | -71.09 | -96.29 | -87.40 | |
| Net Cash Used From Financing Activities | -167.76 | -86.96 | 9.12 | -78.42 | -36.79 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | -0.96 | 1.01 | -0.04 | -0.31 | 1.07 | |
| Cash And Cash Equivalents Begin of Year | 3.94 | 2.93 | 2.97 | 3.28 | 3.43 | |
| Cash And Cash Equivalents End Of Year | 2.98 | 3.94 | 2.93 | 2.97 | 4.50 |
14.11.2025
Aarti Drugs Consolidated September 2025 Net Sales at Rs 652.79 crore, up 9.1% Y-o-Y
12.11.2025
Aarti Drugs Standalone September 2025 Net Sales at Rs 578.95 crore, up 6.6% Y-o-Y
18.07.2025
Aarti Drugs Standalone June 2025 Net Sales at Rs 520.96 crore, up 5.68% Y-o-Y
18.07.2025
Aarti Drugs Consolidated June 2025 Net Sales at Rs 590.51 crore, up 6.33% Y-o-Y